FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2161906602> ?p ?o ?g. }

• W2161906602 abstract "This analysis compared the cost-effectiveness of interferon beta-1a (IFNbeta-1a) 44 microg SC with that of other available first-line treatments for relapsing-remitting multiple sclerosis (RRMS) from the German societal perspective in 2008.A decision-analytic model was used to estimate the cost-effectiveness of IFNbeta-1a 44 microg SC given 3 times weekly compared with that of IFNbeta-la 30 microg IM given once weekly, IFNbeta-1b 8 mIU given every other day, and glatiramer acetate 20 mg SC given once daily. Data sources included the published literature, clinical trials, German price/tariff lists, and national population statistics. The time horizon of the model was 4 years, which was the maximum duration of follow-up in published clinical trials.The cost-effectiveness (cost per relapse avoided) of IFNbeta-la 44 microg SC compared with no active treatment was euro51,250, which compared favorably with that of IFNbeta-la 30 microg IM (euro133,770), glatiramer acetate (euro71,416), and IFNbeta-1b (euro54,475). When the cost of disease progression was excluded, the cost per relapse avoided remained favorable for IFNbeta-1a 44 microg SC (euro54,292) compared with the other options (euro143,186, euro72,809, and euro56,816, respectively). Indirect comparison of each available treatment option with the next best alternative indicated that the incremental cost-effectiveness of IFNbeta-la 44 microg SC (euro23,449) was consistent with accepted thresholds. Sensitivity analyses in which the discount rate, frequency of relapse and disease progression, costs of relapse and disease progression, and adherence were varied did not affect the relative outcomes.In this analysis from the German societal perspective, IFNbeta-la 44 microg SC had favorable overall cost-effectiveness versus no active treatment compared with other available disease-modifying drugs for the treatment of RRMS." @default.
• W2161906602 created "2016-06-24" @default.
• W2161906602 creator A5062818266 @default.
• W2161906602 creator A5074188740 @default.
• W2161906602 date "2010-04-01" @default.
• W2161906602 modified "2023-09-25" @default.
• W2161906602 title "A health-economic evaluation of disease-modifying drugs for the treatment of relapsing-remitting multiple sclerosis from the German societal perspective" @default.
• W2161906602 cites W1943280741 @default.
• W2161906602 cites W1964903075 @default.
• W2161906602 cites W1967276269 @default.
• W2161906602 cites W1982044564 @default.
• W2161906602 cites W1983999022 @default.
• W2161906602 cites W2002562924 @default.
• W2161906602 cites W2005506388 @default.
• W2161906602 cites W2015238396 @default.
• W2161906602 cites W2022826476 @default.
• W2161906602 cites W2032404313 @default.
• W2161906602 cites W2036853725 @default.
• W2161906602 cites W2053199643 @default.
• W2161906602 cites W2061097019 @default.
• W2161906602 cites W2074571707 @default.
• W2161906602 cites W2078096723 @default.
• W2161906602 cites W2078358029 @default.
• W2161906602 cites W2080344560 @default.
• W2161906602 cites W2086821310 @default.
• W2161906602 cites W2095081886 @default.
• W2161906602 cites W2097669496 @default.
• W2161906602 cites W2105477343 @default.
• W2161906602 cites W2116810340 @default.
• W2161906602 cites W2119500075 @default.
• W2161906602 cites W2139367012 @default.
• W2161906602 cites W2165547142 @default.
• W2161906602 cites W2168301183 @default.
• W2161906602 cites W2169098250 @default.
• W2161906602 cites W2404245847 @default.
• W2161906602 cites W2704729794 @default.
• W2161906602 cites W4210548604 @default.
• W2161906602 cites W4234254101 @default.
• W2161906602 cites W4243807279 @default.
• W2161906602 cites W4244801936 @default.
• W2161906602 cites W4250145052 @default.
• W2161906602 cites W4299159248 @default.
• W2161906602 doi "https://doi.org/10.1016/j.clinthera.2010.03.019" @default.
• W2161906602 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20435242" @default.
• W2161906602 hasPublicationYear "2010" @default.
• W2161906602 type Work @default.
• W2161906602 sameAs 2161906602 @default.
• W2161906602 citedByCount "23" @default.
• W2161906602 countsByYear W21619066022012 @default.
• W2161906602 countsByYear W21619066022013 @default.
• W2161906602 countsByYear W21619066022014 @default.
• W2161906602 countsByYear W21619066022015 @default.
• W2161906602 countsByYear W21619066022017 @default.
• W2161906602 countsByYear W21619066022018 @default.
• W2161906602 countsByYear W21619066022020 @default.
• W2161906602 countsByYear W21619066022021 @default.
• W2161906602 countsByYear W21619066022022 @default.
• W2161906602 crossrefType "journal-article" @default.
• W2161906602 hasAuthorship W2161906602A5062818266 @default.
• W2161906602 hasAuthorship W2161906602A5074188740 @default.
• W2161906602 hasConcept C112930515 @default.
• W2161906602 hasConcept C126322002 @default.
• W2161906602 hasConcept C142724271 @default.
• W2161906602 hasConcept C203014093 @default.
• W2161906602 hasConcept C2776125615 @default.
• W2161906602 hasConcept C2778577042 @default.
• W2161906602 hasConcept C2779134260 @default.
• W2161906602 hasConcept C2780640218 @default.
• W2161906602 hasConcept C2908647359 @default.
• W2161906602 hasConcept C2908698914 @default.
• W2161906602 hasConcept C2994247566 @default.
• W2161906602 hasConcept C3019080777 @default.
• W2161906602 hasConcept C515549039 @default.
• W2161906602 hasConcept C535046627 @default.
• W2161906602 hasConcept C71924100 @default.
• W2161906602 hasConcept C99454951 @default.
• W2161906602 hasConceptScore W2161906602C112930515 @default.
• W2161906602 hasConceptScore W2161906602C126322002 @default.
• W2161906602 hasConceptScore W2161906602C142724271 @default.
• W2161906602 hasConceptScore W2161906602C203014093 @default.
• W2161906602 hasConceptScore W2161906602C2776125615 @default.
• W2161906602 hasConceptScore W2161906602C2778577042 @default.
• W2161906602 hasConceptScore W2161906602C2779134260 @default.
• W2161906602 hasConceptScore W2161906602C2780640218 @default.
• W2161906602 hasConceptScore W2161906602C2908647359 @default.
• W2161906602 hasConceptScore W2161906602C2908698914 @default.
• W2161906602 hasConceptScore W2161906602C2994247566 @default.
• W2161906602 hasConceptScore W2161906602C3019080777 @default.
• W2161906602 hasConceptScore W2161906602C515549039 @default.
• W2161906602 hasConceptScore W2161906602C535046627 @default.
• W2161906602 hasConceptScore W2161906602C71924100 @default.
• W2161906602 hasConceptScore W2161906602C99454951 @default.
• W2161906602 hasLocation W21619066021 @default.
• W2161906602 hasLocation W21619066022 @default.
• W2161906602 hasOpenAccess W2161906602 @default.
• W2161906602 hasPrimaryLocation W21619066021 @default.
• W2161906602 hasRelatedWork W110791873 @default.
• W2161906602 hasRelatedWork W1970101726 @default.
• W2161906602 hasRelatedWork W1970693461 @default.
• W2161906602 hasRelatedWork W1973327782 @default.

• next